Literature DB >> 24707234

Therapies for nonalcoholic steatohepatitis.

Suzanne Mahady1.   

Abstract

Entities:  

Year:  2013        PMID： 24707234      PMCID： PMC3975978     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  6 in total

Review 1.  The role of thiazolidinediones in non-alcoholic steatohepatitis - a systematic review and meta analysis.

Authors:  Suzanne E Mahady; Angela C Webster; Sarah Walker; Arun Sanyal; Jacob George
Journal:  J Hepatol       Date:  2011-04-14       Impact factor: 25.083

2.  Pioglitazone and vitamin E for nonalcoholic steatohepatitis: a cost utility analysis.

Authors:  Suzanne E Mahady; Germaine Wong; Jonathan C Craig; Jacob George
Journal:  Hepatology       Date:  2012-12       Impact factor: 17.425

Review 3.  Management of nonalcoholic steatohepatitis: an evidence-based approach.

Authors:  Suzanne E Mahady; Jacob George
Journal:  Clin Liver Dis       Date:  2012-06-20       Impact factor: 6.126

4.  Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.

Authors:  Arun J Sanyal; Naga Chalasani; Kris V Kowdley; Arthur McCullough; Anna Mae Diehl; Nathan M Bass; Brent A Neuschwander-Tetri; Joel E Lavine; James Tonascia; Aynur Unalp; Mark Van Natta; Jeanne Clark; Elizabeth M Brunt; David E Kleiner; Jay H Hoofnagle; Patricia R Robuck
Journal:  N Engl J Med       Date:  2010-04-28       Impact factor: 91.245

5.  Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis.

Authors:  Kittichai Promrat; David E Kleiner; Heather M Niemeier; Elizabeth Jackvony; Marie Kearns; Jack R Wands; Joseph L Fava; Rena R Wing
Journal:  Hepatology       Date:  2010-01       Impact factor: 17.425

Review 6.  Lifestyle modification as the primary treatment of NASH.

Authors:  Brent A Neuschwander-Tetri
Journal:  Clin Liver Dis       Date:  2009-11       Impact factor: 6.126
  6 in total
  1 in total

Review 1.  Treatment of nonalcoholic fatty liver disease: Where do we stand? an overview.

Authors:  Asad Dajani; Adnan AbuHammour
Journal:  Saudi J Gastroenterol       Date:  2016 Mar-Apr       Impact factor: 2.485
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.